The implication of this for modelling MLL-AF4 infant leukaemia is that understanding and replicating the cellular context in which the fusion oncogene initiates, most likely in pre-haematopoietic cells, may be required to generate a truly representative disease model. Here, KMT2A is linked to leukemia.